Matinas BioPharma Holdings (MTNB) Capital Expenditures (2013 - 2023)
Matinas BioPharma Holdings (MTNB) recorded Capital Expenditures of $218,000 in FY2023, down 75.6% from $892,000 in FY2022.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) Capital Expenditures (2013 - 2023) Analysis & Trends
Starting with FY2013, Matinas BioPharma Holdings' Capital Expenditures history includes 10 years.
- Annual Capital Expenditures has a five-year compound annual growth rate of -16.5% (FY2018 to FY2023).
- The FY2023 figure is the lowest annual Capital Expenditures since FY2020.
- Per Business Quant data, MTNB's Capital Expenditures was $892,000 in FY2022 (+243.1%), $260,000 in FY2021, $6,000 in FY2020 (-98.5%) and $405,604 in FY2019 (-24.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Matinas BioPharma Holdings | 16.27 Mn | 3.68 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 16,000.00 |
| Dec 31, 2022 | 42,000.00 |
| Sep 30, 2022 | 250,000.00 |
| Jun 30, 2022 | 55,000.00 |
| Mar 31, 2022 | 545,000.00 |
| Dec 31, 2021 | 35,812.00 |
| Mar 31, 2020 | 5,749.00 |
| Sep 30, 2019 | 73,430.00 |
| Jun 30, 2019 | 317,928.00 |
| Mar 31, 2019 | 14,246.00 |
| Sep 30, 2018 | 275,310.00 |
| Jun 30, 2018 | 158,690.00 |
| Mar 31, 2018 | 101,916.00 |
| Dec 31, 2017 | 118,294.00 |
| Sep 30, 2017 | 34,181.00 |
| Dec 31, 2015 | 22,932.00 |
| Sep 30, 2015 | 14,513.00 |
| Jun 30, 2015 | 33,889.00 |
| Mar 31, 2015 | 4,845.00 |
| Dec 31, 2014 | 1.00 |
API Access
Matinas BioPharma Holdings Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();